Pharmaceutical compositions of CETP inhibitors

Details for Australian Patent Application No. 2004222434 (hide)

Owner Japan Tobacco Inc.

Inventors Serigano, Takanori; Sunami, Masaki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004222434

PCT Pub. Number WO2004/082593

Priority 60/493,649 08.08.03 US; 60/460,521 04.04.03 US; 60/455,293 17.03.03 US; 60/477,202 10.06.03 US

Filing date 17 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 3 June 2010

International Classifications

A61K 31/265 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/082593 Priority application(s): WO2004/082593

3 June 2010 Application Accepted

  Published as AU-B-2004222434

30 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222435-Angiotensin-converting enzyme inhibitory peptides

2004222432-Therapeutic and/or preventive agent for chronic skin disease